K00546 - Moligand™,≥98% , CAS No.443798-47-8

CAS: 443798-47-8 Cat. No.: K651273 Formula: C15H13F2N7O2S2 Molecular Weight: 425.44
AVAILABLE TO ORDER
GRADE & PURITY Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
Cdk1/2 Inhibitor III|Cdk1/2InhibitorIII|5-Amino-3-((4-(aminosulfonyl)phenyl)amino)-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide|5-Amino-3-((4(aminosulfonyl)phenyl)amino)-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide|5-amino-N-(2,6-difluorophenyl)-3-[(4-sulfamoylphenyl)amino]-1H-1,2,4-triazole-1-carbothioamide|1H-1,2,4-Triazole-1-carbothioamide, 5-amino-3-((4-(aminosulfonyl)phenyl)amino)-N-(2,6-difluorophenyl)-|Cdk1/2 Inhibitor III - CAS 443798-55-8|5-amino-N-(2,6-difluorophenyl)-3-(4-sulfamoylanilino)-1,2,4-triazole-1-carbothioamide|CDK 1/2 INHIBITOR|K00546|K-00546|5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Size
USA
Germany (EU)*
Price
Qty
1mg
K651273-1mg
Made to order · 8–12 wks
$89.90
5mg
K651273-5mg
Made to order · 8–12 wks
$239.90
10mg
K651273-10mg
Made to order · 8–12 wks
$399.90
25mg
K651273-25mg
Made to order · 8–12 wks
$699.90
50mg
K651273-50mg
Made to order · 8–12 wks
$999.90
Enter a quantity for the sizes you want to add.

Overview

K00546 is a potent CDK1 and CDK2 inhibitor with IC 50 s of 0.6 nM and 0.5 nM for CDK1/cyclin B and CDK2/cyclin A , respectively. K00546 is also a potent CDC2-like kinase 1 (CLK1) and CLK3 inhibitor with IC 50 s of 8.9 nM and 29.2 nM, respectively .

In Vitro

K00546 binds to the SLK ATP-binding site forming three hydrogen bonds with the kinase hinge residues E109 and C111. The sulphamoyl moiety of K00546 also interacts with the main chain of L40. K00546 (compound 3n) also inhibits PKA, casein kinase-1, MAP kinase (ERK-2), calmodulin kinase, VEGF-R2, GSK-3 and PDGF-Rβ with IC 50 values of 5.2 μM, 2.8 μM, 1.0 μM, 8.9 μM, 0.032 μM, 0.14 μM and 1.6 μM, respectively. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Form:Solid

Specifications

Synonyms
Cdk1/2 Inhibitor III | Cdk1/2InhibitorIII | 5-Amino-3-((4-(aminosulfonyl)phenyl)amino)-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide | 5-Amino-3-((4(aminosulfonyl)phenyl)amino)-N-(2,6-difluorophenyl)-1H-1,2,4-triazole-1-carbothioamide | 5-amino-N-(2,6-difluorophenyl)-3-[(4-sulfamoylphenyl)amino]-1H-1,2,4-triazole-1-carbothioam Show more
Specifications & Purity
Moligand™,≥98%
Biochemical and Physiological Mechanisms
K00546 is a potent CDK1 and CDK2 inhibitor with IC 50 s of 0.6 nM and 0.5 nM for CDK1/cyclin B and CDK2/cyclin A , respectively. K00546 is also a potent CDC2-like kinase 1 (CLK1) and CLK3 inhibitor with IC 50 s of 8.9 nM and 29.2 nM, respectively
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade
Moligand™
Action Type
INHIBITOR
Purity
≥98%
Names and Identifiers
SMILES
C1=CC(=C(C(=C1)F)NC(=S)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F
IUPAC Name
5-amino-N-(2,6-difluorophenyl)-3-(4-sulfamoylanilino)-1,2,4-triazole-1-carbothioamide
InChIKey
ARIOBGGRZJITQX-UHFFFAOYSA-N
InChI
1S/C15H13F2N7O2S2/c16-10-2-1-3-11(17)12(10)21-15(27)24-13(18)22-14(23-24)20-8-4-6-9(7-5-8)28(19,25)26/h1-7H,(H,21,27)(H2,19,25,26)(H3,18,20,22,23)
Isomeric SMILES
C1=CC(=C(C(=C1)F)NC(=S)N2C(=NC(=N2)NC3=CC=C(C=C3)S(=O)(=O)N)N)F
Molecular Weight
425.44
Reaxys
10206251
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=10206251&ln=

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassBenzenoids
ClassBenzene and substituted derivatives
SubclassBenzenesulfonamides
Intermediate Tree Nodes Not available
Direct ParentBenzenesulfonamides
Alternative Parents Benzenesulfonyl compounds  Aniline and substituted anilines  Fluorobenzenes  Organosulfonamides  Aryl fluorides  Triazoles  Heteroaromatic compounds  Aminosulfonyl compounds  Secondary amines  Azacyclic compounds  Primary amines  Organopnictogen compounds  Organofluorides  Organic oxides  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteromonocyclic compounds
Substituents Benzenesulfonamide - Benzenesulfonyl group - Aniline or substituted anilines - Fluorobenzene - Halobenzene - Aryl fluoride - Aryl halide - Organosulfonic acid amide - Azole - Organic sulfonic acid or derivatives - Organosulfonic acid or derivatives - Heteroaromatic compound - Sulfonyl - 1,2,4-triazole - Aminosulfonyl compound - Secondary amine - Organoheterocyclic compound - Azacycle - Primary amine - Organosulfur compound - Organonitrogen compound - Organofluoride - Organohalogen compound - Hydrocarbon derivative - Organic nitrogen compound - Organic oxygen compound - Amine - Organopnictogen compound - Organic oxide - Aromatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Associated Targets(Human)
CDK1 Tchem Cyclin-dependent kinase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CDK2 Tchem Cyclin-dependent kinase 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
FLT1 Tclin Vascular endothelial growth factor receptor 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CLK3 Tchem Dual specificity protein kinase CLK3 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CLK1 Tchem Dual specificity protein kinase CLK1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABL1 Tclin Tyrosine-protein kinase ABL (18331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGF1R Tclin Insulin-like growth factor I receptor (8605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAPK3 Tchem Death-associated protein kinase 3 (2108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK11 Tchem MAP kinase p38 beta (2785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GSK3B Tclin Glycogen synthase kinase-3 beta (11785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCZ Tchem Protein kinase C zeta (2414 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAP2K6 Tchem Dual specificity mitogen-activated protein kinase kinase 6 (1284 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MYLK Tchem Myosin light chain kinase, smooth muscle (1267 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1G1 Tchem Casein kinase I gamma 1 (2496 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR2 Tclin Fibroblast growth factor receptor 2 (3405 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
STK3 Tchem Serine/threonine-protein kinase MST2 (3069 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1D Tchem Casein kinase I delta (4546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAMK2B Tchem CaM kinase II beta (1626 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK6 Tclin Cyclin-dependent kinase 6 (1724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHEK2 Tchem Serine/threonine-protein kinase Chk2 (4015 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDPK1 Tchem 3-phosphoinositide dependent protein kinase-1 (3758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKAA2 Tchem AMP-activated protein kinase, alpha-2 subunit (1328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHUK Tchem Inhibitor of nuclear factor kappa B kinase alpha subunit (3170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAPK2 Tchem Death-associated protein kinase 2 (740 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AURKB Tchem Serine/threonine-protein kinase Aurora-B (6805 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA4 Tchem Ribosomal protein S6 kinase alpha 4 (2104 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ROCK1 Tclin Rho-associated protein kinase 1 (4723 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIM1 Tchem Serine/threonine-protein kinase PIM1 (9629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PKN2 Tchem Protein kinase N2 (1991 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSK Tchem Tyrosine-protein kinase CSK (2395 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK3 Tclin Tyrosine-protein kinase JAK3 (8349 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA5 Tchem Ribosomal protein S6 kinase alpha 5 (3355 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCE Tchem Protein kinase C epsilon (1520 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCG Tchem Protein kinase C gamma (2471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKCI Tchem Protein kinase C iota (2821 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKD1 Tchem Protein kinase C mu (1904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAF1 Tclin Serine/threonine-protein kinase RAF (4169 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SYK Tclin Tyrosine-protein kinase SYK (7372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITK Tclin Tyrosine-protein kinase ITK/TSK (3699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK1 Tclin Tyrosine-protein kinase JAK1 (8569 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA1 Tchem Ribosomal protein S6 kinase alpha 1 (2796 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPS6KA6 Tchem Ribosomal protein S6 kinase alpha 6 (2027 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Associated Targets(non-human)
Prkcd Protein kinase C delta (192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prkcb Protein kinase C beta (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr4 Fibroblast growth factor receptor 4 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Fgfr3 Fibroblast growth factor receptor 3 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Camk2g CaM kinase II gamma (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tec Tyrosine-protein kinase TEC (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mechanisms of Action
Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot NumberCertificate TypeDateItem
G2624337G2624337Certificate of AnalysisFeb 24, 2026 K651273
G2624338G2624338Certificate of AnalysisFeb 24, 2026 K651273
G2624339G2624339Certificate of AnalysisFeb 24, 2026 K651273
G2624340G2624340Certificate of AnalysisFeb 24, 2026 K651273
G2624341G2624341Certificate of AnalysisFeb 24, 2026 K651273
Chemical and Physical Properties
SolubilityDMSO : 100 mg/mL (235.05 mM; Need ultrasonic)
Molecular Weight425.4
XLogP32.200
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count10
Rotatable Bond Count4
Exact Mass425.054 Da
Monoisotopic Mass425.054 Da
Topological Polar Surface Area181.000 Ų
Heavy Atom Count28
Formal Charge0
Complexity647.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Safety and Hazards(GHS)
Reaxys
10206251
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=10206251&ln=
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No tested applications are listed for this specific item. The following are general, non-item-specific protocols for small-molecule screening compounds.

Biochemical assay stock handling (general)

  • Dissolve in dry DMSO to 10–50 mM. Vortex and, if necessary, sonicate briefly. Filter through 0.22 μm PTFE if particulates persist.
  • Prepare single-use aliquots (10–50 μL) in inert, low-bind tubes. Store at −20°C; avoid repeated freeze–thaw.

Cell-based assays (general)

  • Dilute from DMSO stocks into pre-warmed culture medium to the desired concentration, maintaining constant vehicle across controls. Typical DMSO ≤0.1–0.5% v/v.
  • Include cytotoxicity/viability counter-screens and orthogonal readouts to exclude assay interference.

Biophysical assays (general)

  • For DSF, keep final dye and DMSO within validated ranges; perform serial dilutions in assay buffer with matched vehicle controls.

Documentation

  • Record lot number, stock concentration, preparation date, and cumulative thaw cycles. Confirm integrity by periodic LC–MS.
Biological Roles

No biological function or mechanistic role is specified for this item. Without a disclosed structure or target annotation, definitive statements cannot be made.

General considerations for library ligands (not item-specific)

  • Intended use: exploratory research to interrogate protein function, pathways, or phenotypes. Any observed activity must be verified with orthogonal assays and counter-screens (e.g., aggregators, redox cyclers, PAINS filters) before drawing conclusions.
  • Off-target risks: Small molecules may show assay interference (fluorescence quenching, redox activity, metal chelation). Employ appropriate controls and biophysical validation.
  • ADME liabilities: Solubility, permeability, and stability (microsomal/chemical) are structure-dependent. Generate tiered profiling data after initial hits are observed.
Buffer Applications

This product is a small-molecule library member rather than a buffering reagent. No dedicated buffer system or pKa information is available.

Practical notes (general; not item-specific)

  • Prepare assay buffers independently of the compound; maintain constant organic cosolvent (e.g., 0.1–1% DMSO) across all wells.
  • If pH-dependent solubility is suspected (undisclosed here), construct a solubility–pH profile using Britton–Robinson or Good’s buffers to guide formulation.
Green Alternatives

Specific green chemistry considerations depend on the compound’s structure and solvent needs, which are not provided. The following guidance is general for handling small-molecule screening ligands and associated workflows.

  • Prefer greener solvents for preparative work when feasible: ethanol, isopropanol, ethyl acetate, 2-MeTHF (over THF), CPME (over diethyl ether), propylene carbonate (over DMF/DMAc) when compatible with solubility and stability.
  • For assay dilution, minimize DMSO carryover (≤0.5–1%) and consider ethanol or PEG-400 co-solvent when biologically acceptable.
  • Employ microscale screening to reduce solvent use; adopt 96/384-well formats and acoustic dispensing to lower DMSO volumes.

Illustrative comparison (general; not item-specific)

  • DMSO vs. Ethanol: DMSO offers broader solubility but has higher persistence in wastewater; ethanol is greener but may not dissolve hydrophobic scaffolds.
  • DMF/DMAc vs. Propylene Carbonate: PC is safer and greener but may be more viscous and less miscible in some systems.

Waste minimization

  • Consolidate mother plates, use sealed low-dead-volume storage, and implement solvent recovery where compatible with purity requirements.
Pharmaceutical Uses

No pharmacopeial or formulation role is specified for this item. This product is supplied strictly for research use only.

General guidance (not item-specific)

  • If used as a reference or screening compound in pharmaceutical R&D, confirm identity/purity by orthogonal methods (e.g., qNMR, LC–MS) and document storage/handling history.
  • Do not use in humans or clinical settings. No excipient status or compendial monograph is indicated.
  • For preformulation studies, determine solubility in pharmaceutically relevant vehicles only after structure and safety data are confirmed via CoA/SDS.
Physical Properties

Item-specific physicochemical constants are not provided in the current record. Always defer to the CoA/SDS for verified values relevant to your lot.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting/Boiling Point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density, Refractive Index: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa, logP/logD, TPSA, HBD/HBA counts: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility profile (water, DMSO, MeOH, buffers): Not specified for this item; refer to CoA/Spec Sheet.

General guidance (literature/practice for small-molecule libraries; not item-specific)

  • Screening ligands are commonly supplied as solids or DMSO solutions and are often formulated for dissolution in dry DMSO to prepare 10–50 mM stocks. If aqueous work is required, cosolvent systems (e.g., 1–5% DMSO in buffer with surfactant) are typical.
  • Determine exact solubility and stability (hydrolysis/oxidation/photolability) from the item CoA before scale-up or biological testing.
Quality & Grades
  • Grade/Purity: Moligand™

What Moligand™ indicates (program-level description; not item-specific)

  • Moligand™ denotes inclusion in a small-molecule/ligand screening library intended for discovery workflows (e.g., target engagement, binding, chemical biology, SAR starting points). Entries typically include confirmed identity and purity by orthogonal methods (e.g., LC–MS, HPLC), but exact specifications vary by item.

Item-specific details

  • Assay/Purity, Residual Solvent, Water Content, Metal Content, Stabilizers, UV Cutoff: Not specified for this item; refer to CoA/Spec Sheet.

Implications for use

  • Library-grade compounds are generally suitable for biochemical and cell-based screening when dissolved under sterile and anhydrous conditions. For analytical or synthetic applications requiring stringent specifications (trace metals, Karl Fischer, low-UV), verify that this lot meets your criteria on the CoA.
  • If the item is supplied as a solution (e.g., in DMSO), confirm concentration, stabilizers, and storage interval on the label/CoA before use.

Documentation

  • For regulated workflows (QC, GLP), retain the batch-specific CoA and ensure internal method suitability (HPLC/UPLC or LC–MS) to verify purity upon receipt.
Reaction & Applications

Manufacturer Applications: Not specified beyond inclusion in a small-molecule/compound library (Moligand™). No reaction-class guidance can be provided without a disclosed structure.

General research applications for library members (not item-specific)

  • Biochemical/biophysical screening: target binding, thermal shift (DSF), SPR, MST, ITC.
  • Cellular assays: phenotypic screens, pathway reporter assays (ensure solvent tolerance and cytotoxicity windows).
  • Chemoproteomics: if electrophilic/photoreactive handles are present (unknown here), probe derivatization may enable target capture.
  • Analytical standards: retention-time markers or MS/MS library expansion after identity confirmation.

Practical tips

  • Verify identity and purity by LC–MS/HPLC upon receipt; record retention time and MS for your system.
  • Prepare master stocks in DMSO, aliquot to avoid freeze–thaw cycles, and track cumulative DMSO exposure of cells/enzymes.
  • If using in reactions (synthetic context), determine functional group compatibility and reactivity from the CoA/structure before selecting bases, nucleophiles, or redox conditions.
Reaction Conditions

Item-specific reaction conditions cannot be recommended without a disclosed structure and functional group inventory.

General guidance for handling small-molecule ligands (not item-specific)

  • Stock preparation: 10–50 mM in dry DMSO; aliquot under inert gas if sensitive. Store at −20°C as directed.
  • Assay conditions: Keep final DMSO ≤0.5–1% v/v in biochemical assays and typically ≤0.1–0.5% in cellular assays, subject to cell tolerance.
  • Analytical QC: LC–MS compatible mobile phases (e.g., water/ACN or water/MeOH with 0.05–0.1% formic acid or ammonium acetate) are commonly effective for library compounds.
  • Stability checks: Incubate at assay temperature in matrix (buffer/serum) and monitor by LC–MS for 2–24 h to ensure no rapid degradation or adsorption.

Yields/kinetics: Not applicable; no synthetic transformation is defined for this item.

Safety & Handling

Hazard classification is not provided for this specific item; always consult the SDS for authoritative information.

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word / Pictograms / H-Statements: Not specified for this item; refer to SDS.

General laboratory precautions (applicable to research-grade organic small molecules)

  • PPE: Wear lab coat, safety glasses, and appropriate chemical-resistant gloves. Handle solids/powders in a fume hood to avoid inhalation of dust or aerosols.
  • Avoid contact with skin and eyes; prevent ingestion and inhalation. Wash thoroughly after handling.
  • Storage incompatibilities: Unknown for this item; as a precaution, segregate from strong oxidizers, strong acids/bases, and ignition sources until specific data are confirmed.
  • First aid (overview; defer to SDS): Inhalation—move to fresh air; Skin/Eye contact—rinse with water for several minutes; Ingestion—rinse mouth. Seek medical attention if symptoms persist.
  • Spill response: Avoid dust generation; collect mechanically or with inert absorbent; dispose of according to institutional and regulatory guidelines.

Special risks

  • Without structural information, assume potential for light/air/moisture sensitivity typical of certain heterocycles or functionalized aromatics. Store as directed and minimize freeze–thaw and air exposure.
  • Always verify any peroxide-forming, sensitizing, or reactive functional groups on the CoA/SDS before heating or concentrating.
Solvent Selection

Item-specific solvent compatibility and solubility are not provided in this record; consult the CoA for definitive guidance.

General solvent strategy for library ligands (literature/practice; not item-specific)

  • Primary stock solvent: Anhydrous DMSO is commonly used to 10–50 mM. Filter through 0.22 μm if particulate is observed.
  • Cosolvent systems for assays: 0.1–2% DMSO in aqueous assay buffers; add surfactants (e.g., 0.01% Tween-20) only if compatible with the biology.
  • Alternative solvents: Acetonitrile, methanol, ethanol may be used depending on polarity. Use minimal organic percentages to avoid assay interference.
  • Light/air sensitivity: If the structure includes photo- or redox-sensitive motifs (unknown here), use amberware, nitrogen backfill, and prepare fresh working dilutions.

Quick comparison (general; not item-specific)

  • DMSO: Highest solvating power for diverse chemotypes; may affect some targets/cells at >0.5–1%.
  • MeOH/EtOH: Miscible with water; lower solvating power; more benign for some assays.
  • ACN: Good for LC and analytical prep; limited biocompatibility; useful for crash/precipitation steps.
Storage & Reconstitution

Item-specific conditions

  • Storage: Store at −20°C (as provided in Product Data).
  • Shipping: Ice chest + ice pads.
  • Appearance, solvent of supply, stabilizers: Not specified for this item; refer to CoA/Spec Sheet.

General reconstitution guidance for Moligand library compounds (not item-specific)

  • If supplied as a solid: Allow container to equilibrate to room temperature in a desiccator before opening to avoid condensation. Dissolve in anhydrous DMSO to prepare 10–50 mM master stocks unless the CoA specifies otherwise.
  • If supplied as a DMSO solution: Mix gently after thawing; spin briefly to collect contents. Do not vortex viscous solutions vigorously to avoid aeration.
  • Aliquoting: Prepare single-use aliquots to minimize freeze–thaw. Backfill headspace with inert gas for air-sensitive compounds and store in amber vials if light-sensitive.
  • Stability: Without structure-specific data, assume working solutions are stable for hours to a day at room temperature and several days at 2–8°C; verify stability empirically by LC–MS/HPLC.

Disposal

  • Dispose of unused material and waste according to institutional chemical safety protocols. This product is for research use only and not for human or veterinary use.
Structure & Identity

Concise identification details for this Moligand library member. Item-specific identifiers are limited in the current record; consult the CoA/Spec Sheet for definitive structure data.

  • SKU: K651273
  • Product Name: K00546 (Moligand library member)
  • CAS: 443798-47-8 (as provided)
  • PubChem CID: 5330812 (as provided)
  • InChIKey: 12950 (as provided; note: this appears non-standard/truncated — verify against CoA/SDS)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural description

  • Item-specific 2D/3D structural features (ring systems, heteroatoms, stereochemistry, functional groups): Not specified for this item; refer to CoA/Spec Sheet.

Notes

  • This listing belongs to a curated small-molecule/compound library (Moligand™). Library entries typically include full structure, purity, and spectral data on the accompanying Certificate of Analysis. If you require structure-confirming data (1H/13C NMR, LC–MS, HRMS), request the CoA prior to use or screening.
Synthetic Utility

Synthetic reactivity cannot be discussed without the chemical structure. The information below is general for small organic ligands and building blocks and should not be construed as item-specific.

General possibilities (not item-specific)

  • If the molecule bears halogens, sulfonyl, boron, or pseudohalide handles, it may participate in cross-couplings (Suzuki–Miyaura, Buchwald–Hartwig, Sonogashira, etc.).
  • If carbonyl or heteroatom nucleophiles/electrophiles are present, standard condensations, reductions, or oxidations could be applicable.
  • Protecting-group strategies, late-stage functionalization, or diversification (amide coupling, SNAr, C–H activation) depend entirely on functional groups to be verified on the CoA.

Recommendation

  • Obtain the structural dossier from the CoA, then map functional groups to reaction classes and confirm compatibility (base/acid/redox, temperature, metal catalysts) before planning derivatizations.
Target Specificity

No target, mode of action, or binding specificity is provided for this Moligand library member. There are no antibody/biologic attributes applicable to this product.

  • Target/Pathway: Not specified for this item; refer to CoA/Spec Sheet or screening campaign documentation.
  • Species reactivity, clone, isotype: Not applicable to small molecules.

Frequently Asked Questions

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?20 °C. Freezer storage is required to maintain the specified shelf life.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 443798-47-8, the molecular formula is C15H13F2N7O2S2, and the molecular weight is 425.44 g/mol. InChIKey ARIOBGGRZJITQX-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.